Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.

Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...

Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, continues to drive ...

In total, 331,590 bottles of Cinacalcet tablets manufactured by Dr. Reddy's Laboratories, Inc. have been recalled due to ...

King’s College Hospital London in Dubai is proud to announce the introduction of a revolutionary new technology in thyroid ...

StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical ...

The Danish pharma group is pledging $285 million in upfront and milestone payments for the lead GLP-1 asset in the ...

A study on kidney donors reveals persistent metabolic changes, including elevated PTH and reduced calcitriol, impacting bone ...

The endocrine actions of FGF23, in association with parathyroid hormone and vitamin D, mobilize sodium–phosphate cotransporters that control renal phosphate transport in proximal tubular ...

These diverse observations were interpreted in accordance with current knowledge of vitamin D and parathyroid hormone interrelations. The acquired excretory abnormality involving amino acid and ...

Calcimimetics suppress the secretion of parathyroid hormone by sensitizing the parathyroid calcium receptor to serum calcium. Cinacalcet (Sensipar ® /Mimpara ®, Amgen Inc., Thousand Oaks ...

Calcium and Vitamin D are essential for properly developing teeth, bones, and muscles.But can you have vitamin D and calcium together? Turns out,Vitamin D actually can increase the amount of calcium ...